Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1

MLA

Millennium Pharmaceuticals, et al. Association between Response Kinetics and Outcomes in Relapsed/Refractory Multiple Myeloma: Analysis from TOURMALINE-MM1. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1286576493&authtype=sso&custid=ns315887.

APA

Millennium Pharmaceuticals, Garderet, L., Laubach, J. P., Stoppa, A.-M., Hari, P., Cavo, M., Ludwig, H., Mateos, M. V., Luptakova, K., Lin, J., Yung, G., Velde, H. van de, Berg, D., Moreau, P., & Richardson, P. G. (2018). Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1.

Chicago

Millennium Pharmaceuticals, Laurent Garderet, Jacob P. Laubach, Anne-Marie Stoppa, Parameswaran Hari, Michele Cavo, Heinz Ludwig, et al. 2018. “Association between Response Kinetics and Outcomes in Relapsed/Refractory Multiple Myeloma: Analysis from TOURMALINE-MM1.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1286576493&authtype=sso&custid=ns315887.